ROSGQ — Rosetta Genomics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.23m
- $9.23m
Annual balance sheet for Rosetta Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 30.9 | 24.4 | 15.6 | 12.4 | 6.16 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.656 | 0.434 | 0.563 | 5.5 | 2.99 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 31.8 | 25 | 16.5 | 19.4 | 9.51 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.546 | 0.874 | 0.822 | 2.98 | 2.44 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 32.5 | 25.9 | 17.3 | 22.4 | 12 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 1.27 | 1.94 | 2.21 | 2.8 | 3.8 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.63 | 2.25 | 2.21 | 2.8 | 7.54 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 30.9 | 23.6 | 15.1 | 19.6 | 4.42 |
| Total Liabilities & Shareholders' Equity | 32.5 | 25.9 | 17.3 | 22.4 | 12 |
| Total Common Shares Outstanding |